Spin-off of the University of the Basque Country and Biogipuzkoa Health Research Institute. Focused on developing First in Class drugs for Neurodegenerative and Rare Diseases. First program in lead optimisation for Retinitis Pigmentosa (RP), and four programs in lead nomination for DMD, DM1, ALS and AD. The lead compounds normalise calcium levels and protect from oxidative stress damage
Company Details
- Employees
- 10
- Founded
- -
- Address
- Avenida De Tolosa, 72, San Sebastián,basque Country 20018,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.miramoonpharma.com
- Keywords
- Smart molecules for Neurodegenerative and Rare disorders, Drug development, Retinitis Pigmentosa.
- HQ
- San Sebastián, Basque Country
Miramoon Pharma Questions
Miramoon Pharma's website is http://www.miramoonpharma.com
Miramoon Pharma's LinkedIn profile is https://es.linkedin.com/company/miramoon.pharma
Miramoon Pharma has
10 employees.
View email and phone details for 10
employees at Miramoon Pharma.
Miramoon Pharma's industry is
Biotechnology Research
Miramoon Pharma's top competitors are
Duponte Group,
Mimo Biosciences,
Plusvitech,
Onena Medicines,
Nanological,
Inhibitec Anticuerpos, S.l.,
Oxolife,
A4cell,
Bioclonal,
Stab Therapeutics.
Miramoon Pharma's categories are Biotechnology Research
Miramoon Pharma's founding year is 2019
